RecruitingNot ApplicableNCT06883448

Implementation of Home Monitoring in Patients With Pulmonary Fibrosis

The SUITS Study: Implementation of Home Monitoring in Patients With Pulmonary Fibrosis


Sponsor

Erasmus Medical Center

Enrollment

220 participants

Start Date

Oct 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this study is to evaluate the impact of structurally replacing half of the outpatient clinic visits for patients with pulmonary fibrosis by home monitoring and video consultations on patient self-management and health(care) outcomes.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • A multidisciplinary ILD team diagnosis of pulmonary fibrosis according to ATS/ERS/JRS/ALAT guidelines;
  • Adults (=/>18 years).

Exclusion Criteria4

  • Patients who are not able to speak, read and/or write in Dutch;
  • Patients with no access to the internet;
  • Patients with a life expectancy of less than 1 year as determined by the treating healthcare provider;
  • Patients who are or have been using a home monitoring program for PF.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTHome monitoring care

Patients in the home monitoring group will receive a home spirometer, pulse oximetry meter, and access to a smartphone or tablet app, where they can perform home based measurements weekly and complete PROMs. Furthermore, this app includes disease specific information and allows for direct communication with the hospital via eConsultation. In the home monitoring group, half of the outpatient clinic visits will alternately be replaced by remote visits via video consultation.


Locations(11)

Department of Pulmonology, Onze Lieve Vrouwe Gasthuis

Amsterdam, Netherlands

Department of Pulmonary Diseases, Rijnstate Hospital

Arnhem, Netherlands

Department of Respiratory Medicine, Amphia Hospital

Breda, Netherlands

Department of Respiratory Medicine, Catharina Hospital

Eindhoven, Netherlands

Department of Pulmonary Medicine, Zuyderland Medical Centre

Heerlen, Netherlands

Department of Pulmonology, Medical Center Leeuwarden

Leeuwarden, Netherlands

Department of Pulmonology, Leiden University Medical Center

Leiden, Netherlands

Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital

Nieuwegein, Netherlands

Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center

Rotterdam, Netherlands

Department of Pulmonology, Haaglanden Medisch Centrum

The Hague, Netherlands

Division of Heart and Lungs, University Medical Center Utrecht and Utrecht University

Utrecht, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06883448


Related Trials